London-based GlaxoSmithKline on Monday launched $940-million open offer to hike its stake in its consumer products company in India -GlaxoSmithKline Consumer Healthcare - from 43.2% to 75%. GSK would pay Rs 3,900 a piece to the shareholders tendering their shares in the open offer, which would begin in January next year. London based company has launched a similar open offer in GlaxoSmithKline ConsumerNigeria Plc to increase its stake to 80%.
The transaction for the consumer products firm would be funded through GSK’s existing cash wealth. It would be earnings-neutral for the first year and accretive thereafter, and will not impact GSK’s long-term share buyback plans.
GSK Consumer Healthcare sells products under brands including, Horlicks, Boost, Viva and Maltova. In over the counter category, it sells Crocin, Eno and Iodex.
| Company Name | CMP |
|---|---|
| Varun Beverages | 452.70 |
| Nestle | 1255.85 |
| Britannia Inds | 5589.75 |
| LT Foods | 419.60 |
| Hatsun Agro Product | 941.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: